Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

NCT06350032 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: preservative-free parenteral treprostinil

Sponsor

AOP Orphan Pharmaceuticals AG